SynthesisScientific reports2025
Maternal exposure to specific endocrine-disrupting chemicals and gestational diabetes mellitus: systematic review and meta-analysis.
Synthesis in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This meta-analysis examines the relationship between exposure to endocrine-disrupting chemicals, such as phthalates and parabens, which are commonly found in cosmetics, and the risk of developing gestational diabetes mellitus (GDM). Following a systematic search of databases (including PubMed, Scopus, and Web of Science), 14 relevant studies involving 9,503 pregnant women from various regions were identified. After excluding one paper, 11 studies were classified as high-quality, while three received acceptable scores and were included in the analysis. The studies assessed the level of chemical exposure by analyzing urine, serum, or plasma samples. Calculated odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the potential association between maternal exposure and GDM development. The pooled analysis indicated no significant correlation between phthalate exposure during pregnancy and GDM risk, with an OR of 1.01 (95% CI: 0.95-1.08). Subgroup analyses based on participants' location and specific phthalate metabolites consistently showed no significant association with GDM. Limited evidence on parabens also failed to demonstrate a clear link with GDM. Although this meta-analysis found no significant link between these substances and GDM, further investigation is necessary to comprehensively assess the cumulative and long-term effects of endocrine-disrupting chemicals on pregnant women.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.